peoplePerson
Kellie N. Smith
Developed the MANAFEST assay to track the tumour-specific T cells that immunotherapy awakens.
Immunologist who built functional assays for mutation-associated neoantigen-specific T cells and applies them to neoadjuvant immunotherapy trials.
Role
Associate Professor of Oncology; Bloomberg~Kimmel Institute
Specialisms
T-cell immunologyNeoantigen-specific T cellsMANAFEST assay
Profiles
| Title | Journal | Year |
|---|---|---|
| MANAFEST: a functional assay to detect and track mutation-associated neoantigen-specific T cells | Cancer Immunology Research | 2018 |
Pages like this
not linked directly; found by shared links- CompanySerova
- PersonMalachi Griffith
- PersonRobert D. Schreiber
Shares Neoantigen, Immune checkpoint inhibitors.
- PersonElizabeth M. Jaffee
Shares Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, Immune checkpoint inhibitors.
- PersonNina Bhardwaj
- PersonTimothy A. Chan
Shares Neoantigen, Immune checkpoint inhibitors.
- IdeaVaccinate against the resistance mutation before it takes over
- PersonSuzanne L. Topalian
Shares Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, Immune checkpoint inhibitors.